Top three stocks that saw heavy demand from buyers in the pre-opening session today Top three stocks that saw heavy demand from buyers in the pre-opening session today These three stocks were the top gainers on BSE in the pre-opening session today. DSIJ Intelligence-2 / Tuesday, April 15, 2025 0 250 Article rating: 3.9 These three stocks were the top gainers on BSE in the pre-opening session today. Read more
Peer Company of Ola Electric, Revolt Motors, Begins Operations in Nepal with First Dealership in Kathmandu Peer Company of Ola Electric, Revolt Motors, Begins Operations in Nepal with First Dealership in Kathmandu The stock has delivered a remarkable 2,000 per cent multibagger return in 5 years. Investors should monitor this Small-Cap company closely. DSIJ Intelligence-2 / Tuesday, April 15, 2025 0 128 Article rating: 4.7 The stock has delivered a remarkable 2,000 per cent multibagger return in 5 years. Investors should monitor this Small-Cap company closely. Read more
2,000 Per cent Returns: Poonawala Backed NBFC Launches Gold Loan Business 2,000 Per cent Returns: Poonawala Backed NBFC Launches Gold Loan Business In the last one year the stock price has given negative 23 per cent return while in 5 years it has given multibagger returns of 2,040 per cent. DSIJ Intelligence-2 / Tuesday, April 15, 2025 0 108 Article rating: 5.0 In the last one year the stock price has given negative 23 per cent return while in 5 years it has given multibagger returns of 2,040 per cent. Read more
Markets Poised for Gap-Up Start as Tech Rally and Tariff Easing Lift Global Markets Markets Poised for Gap-Up Start as Tech Rally and Tariff Easing Lift Global Markets On April 11, 2025, foreign institutional investors (FII) sold shares worth Rs 2,519.03 crore, while domestic institutional investors (DII) bought shares worth Rs 3,759.27 crore. DSIJ Intelligence-2 / Tuesday, April 15, 2025 0 135 Article rating: 5.0 Read more
Pharma company receives final ANDA approval for Rivaroxaban Tablets USP, 2.5mg & tentative approval for other strengths of Rivaroxaban Tablets USP Pharma company receives final ANDA approval for Rivaroxaban Tablets USP, 2.5mg & tentative approval for other strengths of Rivaroxaban Tablets USP Aurobindo Pharma Limited announced obtaining the last approval from the US Food & Drug Administration (USFDA) for Rivaroxaban Tablets USP, 2.5 mg. DSIJ Intelligence-1 / Monday, April 14, 2025 0 161 Article rating: 5.0 The biosimilars division alongside niche product development represents Aurobindo Pharma's main focus areas where its 1500 scientists dedicate their efforts. Read more